Mean corpuscular volume, or MCV, is calculated by dividing the hematocrit (the percentage of blood occupied by red blood cells) by the red blood cell count, then multiplying by ten. The result is expressed in femtoliters (fL), a unit so small that each red blood cell occupies roughly 80 to 100 of them. That formula has been the standard since the 1930s, but most labs today no longer calculate MCV from that equation at all. Modern blood analyzers measure each red blood cell individually as it passes through a sensor, then report the average volume directly.
The Classic Formula
The original approach to MCV requires two lab values you can find on any complete blood count (CBC) report: hematocrit (Hct) and red blood cell count (RBC). Hematocrit is listed as a percentage or a decimal fraction, and RBC count is reported in millions per microliter. The math is straightforward: divide the hematocrit by the RBC count. If hematocrit is expressed as a percentage, multiply by ten to convert to femtoliters. So if your hematocrit is 45% and your RBC count is 5.0 million per microliter, MCV equals (45 ÷ 5.0) × 10, which gives you 90 fL.
This formula works because hematocrit represents the total volume of red cells in a given volume of blood, and dividing by the number of cells gives you the average volume per cell. It is a derived value: only as accurate as the two measurements feeding into it. For decades, hematocrit was measured by spinning a tube of blood in a centrifuge and reading the height of the packed red cell column against the total blood column height. That centrifuged, or “spun,” hematocrit was the gold standard and is still used in some settings.
How Modern Analyzers Measure MCV Directly
If you have had blood drawn at a hospital or clinic in the last few decades, your MCV almost certainly was not calculated from a formula. Automated hematology analyzers measure the volume of each red blood cell as it passes through a sensor, then average all those individual measurements. The hematocrit on your report is actually the derived value now, computed by multiplying the directly measured MCV by the RBC count, which reverses the classic formula.
The most common method is electrical impedance, based on the Coulter principle. Your blood is diluted heavily and then drawn through a tiny opening, roughly 50 micrometers in diameter, with electrodes on either side. Each cell passing through the opening displaces conducting fluid and creates a brief spike in electrical resistance. The height of that spike is proportional to the cell’s volume. The analyzer records hundreds of thousands of these pulses, builds a histogram of cell sizes, and reports the mean as MCV.
A second approach uses light scattering. A laser beam hits each cell as it flows past in a thin stream, and the pattern of scattered light is analyzed to determine cell volume. Some systems measure scattered-light intensity at two angles and use optical theory to derive both cell volume and hemoglobin concentration for each individual red blood cell, which allows the analyzer to report not just an average but a full distribution of sizes and hemoglobin levels.
Both methods are fast and highly reproducible, but they can occasionally be fooled. The electrical impedance method measures the volume of the cell as it exists in the diluted sample, which may not be the same as its volume inside your bloodstream if something about the sample or the diluent changes the cell’s shape or size.
What Counts as a Normal MCV
For adults, most labs report a reference range of roughly 80 to 100 fL. Values below 80 fL are called microcytic (small cells), and values above 100 fL are called macrocytic (large cells). Those cutoffs are widely used but not set in stone; some labs use slightly different boundaries, and the range shifts depending on age and, to a lesser degree, sex.
In children, MCV follows a distinctive pattern. Newborns have large red blood cells, with MCV values commonly above 100 fL. Over the first several months of life, MCV drops considerably, reaching its lowest point during the second year before gradually climbing again throughout childhood and adolescence. A two-year-old with an MCV of 75 fL might be perfectly normal, while the same value in an adult would prompt investigation.
In adults, MCV tends to creep upward with age. A large study analyzing data from patients aged 1 to 90 found that MCV increased steeply during childhood and adolescence, with a slower but steady rise continuing through adulthood. Among adults over 40, men tended to have slightly higher MCV values than women. These age-related shifts are modest, usually a few femtoliters per decade, but they can matter when a value lands right at the edge of the reference range.
When MCV Is Low
A low MCV tells you the red blood cells are smaller than expected. The most common reason is that cells cannot pack enough hemoglobin inside, which is the protein that gives them both their color and their function. Since hemoglobin is what fills most of the cell’s interior, anything that reduces hemoglobin production tends to shrink the cell.
Iron deficiency is the leading cause. Iron is a core component of hemoglobin, and when the supply runs short, the bone marrow produces cells that are both smaller and paler than normal. One study investigating the causes of microcytosis in a hospital population found that iron deficiency accounted for about 35% of cases. The next most frequent causes were forms of thalassemia, inherited conditions in which the body makes abnormal hemoglobin chains. Together, alpha-thalassemia trait and beta-thalassemia trait accounted for roughly half of the remaining cases. Chronic inflammatory conditions and the anemia that accompanies them also drive MCV down, though usually less dramatically than iron deficiency or thalassemia.
Distinguishing iron deficiency from thalassemia trait matters because the treatments are completely different. Iron supplements correct iron deficiency; giving iron to someone with thalassemia trait is unnecessary and can cause iron overload. Your doctor will typically combine MCV with other lab values, including ferritin, serum iron, and hemoglobin electrophoresis, to sort this out. One useful clue is the red cell distribution width (RDW), which measures how much the cell sizes vary. Iron deficiency tends to produce cells of uneven sizes (high RDW), while thalassemia trait produces uniformly small cells (normal RDW). A classification system using MCV and RDW together has been shown to improve the distinction between these conditions.
When MCV Is High
An elevated MCV means the red blood cells are larger than usual. The list of causes is different from microcytosis, and sometimes the cause is not a disease at all. Alcohol use is the single most common driver of macrocytosis in many populations. One study evaluating patients with high MCV found that alcohol was the identified factor in about 37% of cases, vitamin B12 deficiency accounted for roughly 24%, and medications explained about 13%. Together, those three causes covered nearly three-quarters of all macrocytosis cases. Other contributors included folate deficiency, liver disease, myelodysplastic syndromes, and chronic kidney disease.
Vitamin B12 and folate deficiencies cause macrocytosis because both nutrients are essential for DNA synthesis during cell division. When DNA replication slows down, the developing red blood cell continues to grow but divides less often, resulting in fewer, larger cells released into the bloodstream. Alcohol, on the other hand, seems to directly alter how the bone marrow produces red cells, and it can also contribute to folate deficiency through poor diet and impaired absorption.
Several common medications can raise MCV as a side effect, including certain chemotherapy drugs, anticonvulsants, and antiretroviral medications used in HIV treatment. In these cases, the elevated MCV is an expected consequence of the medication rather than a sign of a new problem. Your doctor will usually note this and monitor it without changing treatment unless the MCV rises to an extreme degree or is accompanied by worsening anemia.
Things That Can Throw Off MCV Results
Not every abnormal MCV reflects a genuine change in your red blood cells. Several conditions and sample-handling issues can produce artificially high or low readings, and recognizing these artifacts prevents unnecessary workups.
Cold agglutinins are one well-known culprit. These are antibodies that cause red blood cells to clump together at low temperatures. When clumped cells pass through an impedance sensor, the analyzer may count each clump as a single very large cell, inflating both the MCV and the hematocrit while the red blood cell count drops. Hemoglobin concentration stays accurate because it is measured chemically, not by counting cells. Warming the sample to body temperature before running it through the analyzer usually resolves the problem.
Severe hyperglycemia can also produce a falsely elevated MCV. When blood from a patient with extremely high blood sugar is mixed with the analyzer’s diluent, the osmotic imbalance causes water to rush into the red cells, swelling them. The analyzer faithfully reports the swollen volume, and the MCV comes back high even though the cells are normal-sized in the patient’s own bloodstream. This effect has been documented across multiple generations of automated counters.
Very high white blood cell counts, sometimes seen in leukemias, can interfere with multiple CBC parameters. A white blood cell count above about 100,000 per microliter may cause turbidity that affects hemoglobin measurement and can also distort the red blood cell count and MCV. Depending on the severity, these errors may or may not be clinically meaningful, but lab staff are trained to flag such samples for manual review.
Sample age matters too. If a blood tube sits at room temperature for too long before being analyzed, the red blood cells gradually swell as they absorb water. One study found that MCV increased significantly over a 72-hour period when samples were stored at room temperature, while refrigerated samples remained stable. Most labs have policies requiring CBC samples to be run within a set window, but delays happen, and the swelling effect is real enough to shift a borderline MCV into abnormal territory.
The Red Cell Indices That Travel with MCV
MCV never appears alone on a CBC report. It is always accompanied by two sibling indices: mean corpuscular hemoglobin (MCH) and mean corpuscular hemoglobin concentration (MCHC). MCH tells you the average amount of hemoglobin in a single red blood cell, measured in picograms. MCHC tells you how concentrated the hemoglobin is within the cell, measured in grams per deciliter. MCHC can be thought of as MCH divided by MCV: it describes how densely the hemoglobin is packed into the available cell volume.
These three indices together give a more complete picture than any one of them alone. A low MCV with a low MCH suggests that cells are both small and pale, the classic pattern of iron deficiency. A low MCV with a normal MCHC is more suggestive of thalassemia trait, where cells are small but hemoglobin concentration within each cell remains relatively normal. A high MCV with a normal or slightly low MCHC, meanwhile, points toward B12 or folate deficiency. None of these patterns are diagnostic by themselves, but they help narrow the possibilities before more specific tests are ordered.
Red cell distribution width (RDW) adds another dimension. While MCV reports the average cell size, RDW describes the spread around that average. Two patients can have the same MCV of 75 fL, but one might have a tight cluster of uniformly small cells (low RDW, suggesting thalassemia trait) while the other has a wide mix of sizes (high RDW, suggesting iron deficiency, where newly produced small cells coexist with older normal-sized ones). Combining MCV with RDW has been shown to improve the classification of different types of anemia from CBC data alone.
Mean Reticulocyte Volume and Early Detection
A newer parameter available on some advanced analyzers is mean reticulocyte volume (MRV), which measures the average size of reticulocytes rather than mature red blood cells. Reticulocytes are the youngest red blood cells, released from the bone marrow within the past day or two. Because they reflect what the bone marrow is producing right now, their size can signal a problem days to weeks before the change shows up in MCV.
Mature red blood cells circulate for about 120 days, so MCV is effectively a rolling average over four months of production. If iron stores begin to drop today, the bone marrow will start making smaller cells almost immediately, but those new small cells get averaged in with months’ worth of normal-sized older cells. MCV barely budges at first. MRV, by contrast, reflects only the most recent production and drops much sooner. Research has shown that MRV correlates strongly with MCV but responds earlier, making it a useful tool for catching developing iron deficiency or cancer-related anemia before the standard indices flag a problem.
MRV is not yet reported on every CBC. Its availability depends on the analyzer platform and whether the lab has enabled reticulocyte analysis. When it is available, though, it provides a real-time snapshot of bone marrow output that MCV alone cannot offer.
Why the Spun Hematocrit and the Calculated One Sometimes Disagree
If MCV on modern analyzers is measured directly and hematocrit is derived from it (Hct = MCV × RBC count), then the calculated hematocrit and the old-fashioned spun hematocrit are arrived at by completely different routes. They usually agree closely, but not always. The spun method can overestimate hematocrit slightly because a small amount of plasma gets trapped between the packed red cells. Meanwhile, the calculated method can be thrown off by any of the artifacts that inflate or deflate MCV, such as cold agglutinins or hyperglycemia.
When the two values disagree, it is a useful diagnostic clue. A calculated hematocrit that is significantly higher than the spun hematocrit, for example, might prompt the lab to check for cold agglutinins or other interferences. The spun method remains valuable as a reference check, particularly when automated results look suspicious. Some research groups continue to evaluate how closely the two methods track, keeping the centrifuge method as a benchmark for analyzer performance.
Optical Methods and the Single-Cell Picture
Light-scattering analyzers do something the impedance method cannot: they determine hemoglobin concentration inside each individual cell at the same time they measure its volume. By shining a laser through a single cell in a sheath flow and measuring the pattern of scattered light at two different angles, the system derives both the cell’s volume and its refractive index. Since a red blood cell’s refractive index is a direct function of its hemoglobin concentration, the analyzer converts the optical reading into a hemoglobin value for every single cell.
This means the analyzer does not just report averages. It can generate two-dimensional plots showing the full distribution of cells by both size and hemoglobin concentration. A cluster of small, pale cells stands out visually from a cluster of large, well-filled cells, and mixed populations (for instance, someone with both iron deficiency and B12 deficiency) become visible in a way that average-based indices like MCV would obscure. Some flow cytometry approaches go further, measuring full light-scattering patterns and solving the inverse problem for each cell to extract detailed shape characteristics beyond simple volume.
These single-cell-level data are increasingly useful in hematology, but most routine CBC reports still emphasize the familiar averages. The richer data usually live behind the scenes, available to the lab scientist reviewing flagged samples or to the hematologist who wants to dig deeper into a confusing anemia workup.